‌

US Patent 10532056 Therapeutic compositions, combinations, and methods of use

Patent 10532056 was granted and assigned to Verastem on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1; that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10532056 Therapeutic compositions, combinations, and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.